Galapagos Nv
Officers & Directors
1. Onno van de Stolpe - CEO & Founder
Onno van de Stolpe founded Galapagos NV in 1999 and has been its CEO since then. He is a member of the board of directors of Molecular Partners AG, a biotech company from Switzerland.
2. Andre Hoekema - CFO
Andre Hoekema assumed the role of CFO at Galapagos NV in . He previously served as CFO of Prosensa Holding N.V. He has also held senior finance positions in several companies such as Sonova Holding AG and Siemens.
3. Piet Wigerinck - CSO
Piet Wigerinck joined Galapagos in 2012 as Chief Scientific Officer. He held leadership positions at Janssen R&D for over 20 years, including Vice President of Discovery Sciences and Vice President of Clinical Development.
4. Walid Abi-Saab - CMO
Walid Abi-Saab has been the Chief Medical Officer of Galapagos NV since 2018. He was previously Global Head of Clinical Development and Medical Affairs for General Medicines at Novartis.
Directors:
1. Onno van de Stolpe - CEO & Founder
Onno van de Stolpe founded Galapagos NV in 1999 and has been its CEO since then. He is a member of the board of directors of Molecular Partners AG, a biotech company from Switzerland.
2. Raj Parekh - Chairman of the Board
Raj Parekh has been a member of the Galapagos NV board of directors since 2011 and has served as Chairman since 2014. He is also Chair of the Board of Trmbr, a company developing novel neurodegenerative disease therapies.
3. Elizabeth Goodwin - Director
Elizabeth Goodwin is a biotech investor and entrepreneur with over 25 years of experience in the industry. She is a non-executive director of several biotech companies, including Alnylam Pharmaceuticals and Five Prime Therapeutics.
4. Bruce G. Phillips - Director
Bruce G. Phillips has served as a member of Galapagos NV board of directors since 200 He is a co-founder and board member of Cleave Biosciences and a former member of the board of directors of Corcept Therapeutics.
5. Katrine Bosley - Director
Katrine Bosley has been a member of the board of directors of Galapagos NV since 2015. She is a partner at Two River, a life science venture capital fund, and serves on the board of several biotech companies.
Galapagos Nv currently has 365 employees.
|
